Effects of topiramate on seizure susceptibility in kainate-kindled rats: Involvement of peripheral-type benzodiazepine receptors

Seizure

Volumn 17, Issue 4, 2008, Pages 358-363

  Chen, Chunfu ^a,b,c   Lang, Senyang ^b   Xu, Gelin ^c   Liu, Xinfeng ^c   Zuo, Pingping ^d  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^d PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Epilepsy; Hippocampus; Peripheral benzodiazepine receptors; PK11195; Rats; Topiramate

Indexed keywords

BENZODIAZEPINE RECEPTOR; KAINIC ACID; SODIUM CHLORIDE; TOPIRAMATE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BEHAVIORAL SCIENCE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DECAPITATION; DOSE RESPONSE; DRUG EFFECT; EVALUATION; HIPPOCAMPUS; IN VITRO STUDY; KINDLING; LATENT PERIOD; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SEIZURE SUSCEPTIBILITY; TEMPORAL LOBE EPILEPSY; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; EXCITATORY AMINO ACID AGONISTS; FRUCTOSE; HIPPOCAMPUS; INDICATORS AND REAGENTS; ISOQUINOLINES; KAINIC ACID; KINDLING, NEUROLOGIC; MALE; PERIPHERAL NERVOUS SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; SEIZURES; SYNAPTOSOMES;

EID: 42749090568     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2007.11.021     Document Type: Article

References (23)

1. Lang S. The role of peripheral benzodiazepine receptors (PBRs) in CNS pathophysiology. Curr Med Chem 9 (2002) 1411-1415
2. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motors seizure. Electroencephlogr Clin Neurophysiol 32 (1972) 281-294
3. Hajós F. An improved method for the preparation of synaptosomal fraction in high purity. Brain Res 93 (1975) 485-489
4. 3H]RO5-4864 in human brain. Eur J Pharmacol 340 (1997) 89-99
5. Hellier J.L., Patrylo P.R., Buckmaster P.S., and Dudek F.E. Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy. Epilepsy Res 31 (1998) 73-84
6. Sperk G. Kainic acid seizures in the rat. Prog Neurobiol 42 (1994) 1-32
7. Veenman L., Leschiner S., Spanier I., Weisinger G., Weizman A., and Gavish M. PK11195 attenuates kainic acid-induced seizures and alterations in peripheral-type benzodiazepine receptor (PBR) protein components in the rat brain. J Neurochem 80 (2002) 917-927
8. Sloviter R.S. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science 235 (1987) 73-76
9. Katzir H., Mendoza D., and Mathern G.W. Effect of theophylline and trimethobenzamide when given during kainate-induced status epilepticus: an improved histopathologic rat model of human hippocampal sclerosis. Epilepsia 41 (2000) 1390-1399
10. Caldiroli E., Marino F., Cosentino M., De-Ponti F., Fietta A.M., Mazzone A., et al. Peripheral benzodiazepine receptor expression on leukocytes and neutrophil function during anticonvulsant monotherapy. Pharmacology 57 (1998) 215-221
11. Sauvageau A., Desjardins P., Lozeva V., Rose C., Hazell A.S., Bouthillier A., et al. Increased expression of "peripheral-type" benzodiazepine receptors in human temporal lobe epilepsy: implications for PET imaging of hippocampal sclerosis. Metab Brain Dis 17 (2002) 3-11
12. Banati R.B., Newcombe J., Gunn R.N., Cagnin A., Turkheimer F., Heppner F., et al. The peripheral-type benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123 (2000) 2321-2337
13. Stephenson D.T., Schober D.A., Smaltig E.B., Mincy E., Gehlert D.R., and Clemens J.A. Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat. J Neurosci 15 (1995) 5263-5274
14. Nakamoto Y., Shiotani T., Watabe S., Nabeshima T., and Yoshii M. Nootropic nefiracetam inhibits proconvulsant action of peripheral-type benzodiazepines in epileptic mutant EL mice. Ann N Y Acad Sci 1025 (2004) 135-139
15. LaRoche S.M., and Helmers S.L. The new antiepileptic drugs: scientific review. JAMA 291 (2004) 605-614
16. Czapinski P., Blaszczyk B., and Czuczwar S.J. Mechanisms of action of antiepileptic drugs. Curr Top Med Chem 5 (2005) 3-14
17. Edmonds Jr. H.L., Jiang Y.D., Zhang P.Y., and Shank R. Topiramate as a neuroprotectant in a rat model of global ischemia-induced neurodegeneration. Life Sci 69 (2001) 2265-2277
18. Yang Y., Li Q., and Shuaib A. Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate. Neuropharmacology 39 (2000) 881-888
19. Kudin A.P., Debska-Vielhaber G., Vielhaber S., Elger C.E., and Kunz W.S. The mechanism of neuroprotection by topiramate in an animal model of epilepsy. Epilepsia 45 (2004) 1478-1487
20. Rigoulot M.A., Koning E., Ferrandon A., and Nehlig A. Neuroprotective properties of topiramate in the lithium-pilocarpine model of epilepsy. J Pharmacol Exp Ther 308 (2004) 787-795
21. Trojnar M.K., Malek R., Chroscinska M., Nowak S., Blaszczyk B., and Czuczwar S.J. Neuroprotective effects of antiepileptic drugs. Pol J Pharmacol 54 (2002) 557-566
22. Grabenstatter H.L., Ferraro D.J., Williams P.A., Chapman P.L., and Dudek F.E. Use of chronic epilepsy models in antiepileptic drug discovery: the effect of topiramate on spontaneous motor seizures in rats with kainate-induced epilepsy. Epilepsia 46 (2005) 8-14
23. Koh S., Tibayan F.D., Simpson J.N., and Jensen F.E. NBQX or topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury. Epilepsia 45 (2004) 569-575